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Introduction
Reversible protein phosphorylation is the major general mech-
anism regulating most physiological processes in eukaryotic 
cells. Hundreds of protein kinases have been identifi  ed to date, 
with signifi  cantly fewer phosphatases found to counteract their 
action. This discrepancy can be explained in part by mecha-
nisms used to control phosphatase activity. Protein phospha-
tase 1 (PP1), a major serine/threonine protein phosphatase 
involved in a wide range of cellular processes, exists in the cell 
as an oligomeric complex. The core catalytic subunit binds a 
spectrum of interacting proteins, termed targeting subunits, 
that modulate both its intracellular localization and substrate 
specifi  city (for review see Cohen, 2002). Most of the known 
targeting subunits, including those targeting PP1 to such sub-
strates as glycogen and myosin, contain a conserved “RVXF” 
motif (consensus Arg/Lys-Val/Ile-Xaa-Phe/Trp; Egloff et al., 
1997) that mediates direct binding to PP1. Using primarily bio-
chemical approaches, >50 PP1 targeting subunits have been 
identifi  ed. However, these most likely cannot account for the 
large number of regulatory pathways in which PP1 plays a 
critical role, suggesting that many targeting subunits remain to 
be discovered.
In addition to the signaling diversity provided by targeting 
subunits, PP1 is also expressed in mammalian cells as three 
closely related isoforms, α, β/δ, and γ, which are encoded by 
separate genes. These isoforms are >89% identical in amino 
acid sequence, with minor differences primarily at their NH2 
and COOH termini (for review see Cohen, 2002). Although 
most biochemical studies have not directly addressed the signif-
icance of the different isoforms, in vivo data show that they 
have distinct subcellular localization patterns (Andreassen 
et al., 1998; Trinkle-Mulcahy et al., 2001). This implies differ-
ences in their specifi  city of interaction with particular targeting 
proteins and hence preferential incorporation into different sig-
naling complexes.
Expression of PP1 isoforms as fusions with fl  uorescent 
protein (FP) tags offers both a means to compare their targeting 
in living cells and a method to recover them from cell lysates 
and analyze the proteins with which they associate. Because 
of the unreliability of commercially available PP1 isoform– 
specifi  c antibodies for immunostaining (Trinkle-Mulcahy et al., 
2003; Lesage et al., 2004), we have gone to great lengths to 
validate the use of these FP fusion proteins as markers for en-
dogenous pools of PP1. FP-tagged PP1 isoforms are function-
ally  active phosphatases with distinct interphase localization 
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rotein phosphatase 1 (PP1) is a ubiquitous serine/
threonine phosphatase regulating many cellular 
processes. PP1α and -γ are closely related iso-
forms with distinct localization patterns, shown here by 
time-lapse microscopy of stably expressed ﬂ   uorescent 
protein fusions. A pool of PP1γ is selectively loaded 
onto chromatin at anaphase. Using stable isotope label-
ing and proteomics, we identiﬁ  ed a novel PP1 binding 
protein, Repo-Man, which selectively recruits PP1γ onto 
mitotic chromatin at anaphase and into the following 
interphase. This approach revealed both novel and 
known PP1 binding proteins, quantitating their relative 
distribution between PP1α and -γ in vivo. When overex-
pressed, Repo-Man can also recruit PP1α to chromatin. 
Mutating Repo-Man’s PP1 binding domain does not dis-
rupt   chromatin binding but abolishes recruitment of PP1 
onto chromatin. RNA interference–induced knockdown 
of Repo-Man caused large-scale cell death by apopto-
sis, as did overexpression of this dominant-negative 
mutant. The data indicate that Repo-Man forms an 
  essential complex with PP1γ and is required for the 
  recruitment of PP1 to chromatin.
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 patterns  (Trinkle-Mulcahy et al., 2001) matching those ob-
served by antibody staining of endogenous PP1 isoforms in 
fi  xed cells (Andreassen et al., 1998). Importantly, these distinct 
localization patterns can be overridden if a single targeting sub-
unit is exogenously overexpressed in cells (Trinkle-Mulcahy 
et al., 2001). In this case, the abundantly expressed targeting 
subunit recruits all PP1 isoforms into the same distribution pat-
tern, suggesting that the expression levels of individual target-
ing sub  units are critical for determining the normal localization 
patterns of PP1 isoforms.
We recently reported the establishment and characteriza-
tion of HeLa cell lines stably expressing FP-PP1γ (Trinkle-
Mulcahy et al., 2003). During interphase, FP-PP1γ was found 
in both cytoplasmic and nucleoplasmic pools, showing a promi-
nent accumulation within nucleoli, whereas time-lapse imaging 
revealed dynamic targeting to specifi  c sites during cell division, 
including kinetochores and chromatin. This changing spatio-
temporal pattern implicates PP1γ in multiple regulatory path-
ways, in agreement with previous work linking its activity to the 
regulation of such cellular events as transcription, chromatin 
remodeling, chromosome condensation and segregation, cyto-
kinesis, and reassembly of the nuclear envelope (for review see 
Ceulemans and Bollen, 2004).
We have now established a HeLa cell line stably express-
ing FP-PP1α. The separate HeLa
EGFP-PP1α and HeLa
EGFP-PP1γ cell 
lines allow the contrasting localization patterns and dynamic 
properties of both isoforms to be analyzed throughout the cell 
cycle and facilitate a comparison of isoform-specifi  c binding 
Figure 1.  Intrinsic differences between 
FP-PP1𝗂 and FP-PP1𝗄 expressed stably in 
mammalian cells. (A–C) FACS analyses show 
no signiﬁ  cant difference in cell cycle distribu-
tion between HeLa
EGFP-PP1α (B) and HeLa
EGFP-PP1γ 
(C) cells and parental HeLa cells (A). (D and E) 
Fluorescence imaging of the stable cell lines 
during interphase reveals distinct localization 
patterns for FP-PP1α (D) and FP-PP1γ (E), with 
nucleoli (arrowheads) and FP-PP1α foci   (arrow) 
marked. (F) FP-PP1α (lane 1) and FP-PP1γ 
(lane 2) immunoprecipitates separated by one-
dimensional SDS-PAGE and silver stained. (G) 
Far Western overlay with 
35S-PP1 shows differ-
ences (arrowheads) between FP-PP1α (lane 2) 
and FP-PP1γ (lane 3) immunoprecipitates. FP 
alone (lane 1) does not coprecipitate PP1 bind-
ing proteins. (H and I) Time-lapse imaging of 
HeLa
EGFP-PP1α (H) and HeLa
EGFP-PP1γ (I) cells dur-
ing mitosis shows differences in localization 
with respect to chromatin (open arrowheads). 
Although both accumulate at kinetochores in 
metaphase (0 min), FP-PP1α is excluded from 
other chromatin regions, reaccumulating within 
the nucleus and nuclear foci (solid arrow) in 
late telophase (36 min), with additional accu-
mulations at the midbody and cell cortex (dot-
ted arrow). In contrast, a large pool of FP-PP1γ 
appears on chromatin at anaphase (3 min) 
and remains there, with a pool reentering nu-
cleoli in late telophase (closed arrowhead). 
(J–M) High-resolution imaging of live mitotic 
HeLa
EGFP-PP1α cells shows the kinetochore local-
ization and chromatin (arrowheads) exclusion 
of FP-PP1α during metaphase (J) and anaphase 
(K), as compared with FP-PP1γ’s kinetochore lo-
calization at metaphase (L) and sudden chro-
matin association at anaphase (M). A pool of 
FP-PP1α is also found on centrosomes (arrows). 
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partners detected via affi  nity  purifi   cation of the respective 
tagged proteins. Mass spectrometry–based proteomics has be-
come a powerful tool for identifying and quantifying the com-
ponents of multiprotein complexes (for review see de Hoog and 
Mann, 2004). More recently, several techniques have exploited 
the use of heavy isotope tags to compare and quantitate relative 
protein levels under different biological conditions (for review 
see Ong and Mann, 2005). In the case of stable isotope labeling 
of amino acids in cell culture (SILAC), cells are metabolically 
labeled through growth in medium containing a specifi  c amino 
acid with either carbon or nitrogen or both substituted with the 
heavy isotopes 
13C and 
15N. By using substituted arginine or 
lysine, proteins are labeled specifi  cally at sites of trypsin cleav-
age, which is convenient for subsequent analysis of tryptic 
peptides by mass spectrometry.
We adapted the triple encoding SILAC approach (Blagoev 
et al., 2004) to identify both novel and known PP1-interacting 
proteins and quantify their relative distribution between PP1α 
and -γ in vivo. One of these proteins, Repo-Man, defi  nes a novel 
pool of PP1, selectively involving the γ isoform, which loads 
onto chromatin at anaphase and remains bound throughout the 
following interphase. Several lines of evidence indicate that the 
Repo-Man–PP1 complex is critical for cell viability.
Results
Comparison of HeLa
EGFP-PP1𝗂 
and HeLa
EGFP-PP1𝗄 stable cell lines
A stable HeLa cell line (HeLa
EGFP-PP1α) was established that ex-
presses PP1α fused at its NH2 terminus to EGFP. As observed 
for the previously characterized HeLa
EGFP-PP1γ stable cell line 
(Trinkle-Mulcahy et al., 2003), this HeLa
EGFP-PP1α cell line is 
homogenous, with >95% of the cells expressing full-length 
catalytically active FP-PP1α at levels similar to those of endog-
enous PP1α (unpublished data). A comparison of the cell cycle 
progression of both HeLa
EGFP-PP1α and HeLa
EGFP-PP1γ cells with 
parental HeLa cells showed that their growth rates are equiva-
lent, and FACS analysis confi  rmed that the relative populations 
in G1, S, and G2/M are similar (Fig. 1, A–C).
Fluorescence imaging of HeLa
EGFP-PP1α and HeLa
EGFP-PP1γ 
cells revealed striking differences in the intrinsic localization 
patterns of the two isoforms (Fig. 1, D and E), similar to those 
observed previously by transient transfection of the fusion pro-
teins (Trinkle-Mulcahy et al., 2001) and by antibody labeling of 
the endogenous proteins (Andreassen et al., 1998). Although 
both are found in the cytoplasm and in the nucleus throughout 
G1, S, and G2, nuclear FP-PP1α is found mainly in a diffuse 
pool and in a few as-yet-unidentifi  ed foci (Fig. 1 D, arrow) and 
largely excluded from nucleoli. In contrast, nuclear FP-PP1γ 
shows a strong accumulation within nucleoli (Fig. 1 E, arrow-
head;  20% of the total nuclear FP-PP1γ; Trinkle-Mulcahy 
et al., 2003).
FP-PP1α and FP-PP1γ also show differences in their dy-
namic distribution during cell division. Time-lapse imaging re-
vealed that although both isoforms accumulate at kinetochores 
in metaphase (Fig. 1, H and I, 0 min), FP-PP1α is predomi-
nantly excluded from other chromatin regions throughout 
  mitosis (open arrowheads). In contrast, low levels of FP-PP1γ 
appear on chromatin at metaphase and there is a sudden and 
rapid recruitment of a larger pool ( 20% of the total cellular 
pool; Trinkle-Mulcahy et al., 2003) onto chromatin as the cell 
enters anaphase (Fig. 1 I, 3 min; Trinkle-Mulcahy et al., 2003). 
Both isoforms also localize at the cortex and midbody in telo-
phase (Fig. 1 H, dotted arrow; Trinkle-Mulcahy et al., 2003). 
FP-PP1α is recruited back into the nucleus much later in telo-
phase (Fig. 1 H, 36 min), whereas FP-PP1γ, which is already 
associated with chromatin, reaccumulates within nucleoli at this 
time (Fig. 1 I, 36 min). High-resolution images of mitotic 
 HeLa
EGFP-PP1α cells more clearly demonstrate the chromatin ex-
clusion of FP-PP1α during metaphase and anaphase (Fig. 1, 
J and K, arrowheads), as compared with FP-PP1γ and its dra-
matic recruitment to chromatin at anaphase (Fig. 1, L and M, 
arrowheads). FP-PP1α also accumulates at centrosomes (Fig. 1 K, 
arrows), which was confi  rmed in both interphase and mitotic 
cells by counterstaining with anti-tubulin antibodies (not 
  depicted) and is in agreement with previous observations 
  (Andreassen et al., 1998). These data imply that PP1α and -γ 
preferentially interact with distinct targeting subunits through-
out the cell cycle and hence play distinct roles.
We thus sought to identify proteins that associate prefer-
entially with either FP-PP1α or FP-PP1γ by immunoprecipi-
tating the fusion proteins from interphase nuclear lysates using 
the same anti-GFP antibody. Although this approach was not 
likely to identify mitosis-specifi  c targeting proteins (i.e., those 
that only bind PP1 during mitosis), we made the assumption, 
based on known regulatory roles for PP1 in transcription and 
chromatin remodeling (for review see Ceulemans and Bollen, 
2004), that the chromatin targeting of PP1γ at anaphase was 
maintained into the following interphase. No clear differences 
were detected when immunoprecipitates were screened by 
SDS-PAGE separation and silver staining (Fig. 1 F). However, 
a far Western assay using in vitro–translated 
35S-labeled PP1 
offered a means to directly detect and compare the subset of 
proteins coprecipitated with FP-PP1α (Fig. 1 G, lane 2) and 
FP-PP1γ (lane 3), which bind directly to the phosphatase. This 
revealed differences in the proteins that coprecipitated with 
the respective isoforms (Fig. 1 G, arrowheads). Immunopre-
cipitation of unfused FP from the HeLa
EGFP cell line, using 
the same  anti-GFP antibody, coprecipitated little or no PP1 
binding proteins, confi  rming the specifi  city of these interactions 
(Fig. 1 G, lane 1).
Combined SILAC/proteomic analysis 
of PP1-interacting proteins
A SILAC proteomic analysis was performed to identify and 
quantify the proteins that immunoprecipitate with anti-GFP 
  antibodies from HeLa
EGFP, HeLa
EGFP-PP1α, and HeLa
EGFP-PP1γ cell 
lines (Fig. 2 A). Sample peptide spectra are shown for three 
  proteins, each with a different arginine ratio (Fig. 2, B–D). 
  Contaminating proteins that copurify with FP alone as well as 
with the FP-PP1 fusion proteins show an arginine ratio of 1:1:1 
(hnRNP K; Fig. 2 B), whereas proteins that copurify specifi  -
cally with either FP-PP1α (NIPP1; Fig. 2 C) or FP-PP1γ 
(Q69YH5; Fig. 2 D) have ratios refl  ecting this enrichment for JCB • VOLUME 172 • NUMBER 5 • 2006  682
heavier forms of arginine. The accuracy of this mass spectro-
metric approach was confi  rmed by Western blot analyses for 
both NIPP1 (Fig. 2 C, inset) and Q69YH5 (Fig. 2 D, inset).
Quantifi  ed proteomic data obtained for the full spectrum 
of proteins identifi  ed in this screen are presented in the graph 
in Fig. 2 E, in which the mean arginine isotope ratio of FP-PP1 
to FP for all quantifi  able peptides is plotted for each protein. 
To facilitate visual comparison, the ratio is shown as a positive 
value for FP-PP1α and a negative value for FP-PP1γ. It is 
clear that although most of the proteins are not specifi  c PP1-
  interacting factors and also copurify with FP alone (ratios  1), 
several proteins show enhanced copurifi  cation with FP-PP1 
(ratios >1.5), and several of these show a preference for one of 
the isoforms. The large fraction of copurifying proteins re-
vealed by isotope labeling to be contaminants prompted us to 
add a selective elution step with an RVXF motif–containing 
peptide that displaces proteins bound to PP1 via this motif 
(data included in Table S1, available at http://www.jcb.org/
cgi/content/full/jcb.200508154/DC1). However, although this 
reduced the number of proteins recovered by  50%, the result-
ing protein mixture still contained a large fraction of contami-
nants, illustrating the utility of the isotope-labeling method and 
the importance of including the unfused FP internal control. 
The PP1-interacting factors revealed by the isotope labeling as 
specifi  c (ratio >1.5) are listed in Table I and include known 
PP1 binding proteins as well as multiple novel factors, a subset 
of which contains an RVXF motif and is thus likely to bind PP1 
directly. Factors lacking this motif may bind PP1 by another 
mechanism or may represent indirectly associated proteins that 
are part of larger PP1 complexes. A comprehensive list of all 
copurifying proteins identifi  ed, including contaminants, is pro-
vided in Table S1.
Figure 2. Identiﬁ  cation of PP1 binding pro-
teins by combined SILAC/mass spectrometry. 
(A) Design of the SILAC experiment. (B–D) 
Sample peptide spectra measured, illustrating 
the shift in peptide mass caused by incorpora-
tion of heavy arginine isotopes. Proteins that 
copurify with FP, FP-PP1α, and FP-PP1γ show a 
1:1:1 ratio (B). Proteins showing speciﬁ  c inter-
actions with either FP-PP1α (C) or FP-PP1γ (D) 
reﬂ  ect that in their arginine ratios, which are in 
agreement with those calculated by quantita-
tion of protein levels via Western blotting 
(C and D, insets). (E) Proteins identiﬁ  ed in one 
experiment, listed in order of database identiﬁ  -
cation score and plotted as relative abundance 
ratios (FP-PP1α/FP plotted as positive values 
and FP-PP1γ/FP plotted as negative values). 
Ratios >1.5 are taken to indicate speciﬁ  c co-
immunoprecipitation with FP-PP1. PP1α and -γ 
peptides were also found, with the expected 
arginine ratios for their respective cell lines.REPO-MAN TARGETS PP1γ TO CHROMATIN • TRINKLE-MULCAHY ET AL. 683
Q69YH5, a novel PP1𝗄-speciﬁ  c 
interacting protein
We were particularly interested in proteins showing preferential 
interaction with PP1γ, with the aim of identifying the mecha-
nism through which this isoform specifi  cally localizes to chro-
matin. One of the novel proteins found to interact preferentially 
with PP1γ contained a canonical RVXF motif, suggesting it 
was a good candidate for further analysis. This protein, Q69YH5, 
whose function is unknown, copurifi  ed with PP1γ in a 3:1 ratio 
over PP1α (Fig. 2 D).
Analysis of the sequence of Q69YH5 revealed stretches 
of basic residues upstream and acidic residues downstream of 
the RVXF motif, which have been shown to enhance interaction 
with PP1 (Zhao and Lee, 1997). Q69YH5 is a unique protein 
with homologues in vertebrates but apparently not in lower eu-
karyotes. The region surrounding the RVXF motif is particularly 
conserved among vertebrate species (Fig. 3 B; see Fig. S1, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200508154/DC1, 
for a full sequence alignment). The human gene is located at 
chromosome 8p21.2, and Northern blot analysis suggests that 
it is ubiquitously expressed (GeneNote; http://genecards. 
weizmann.ac.il/genenote).
To aid the molecular characterization of Q69YH5, we 
raised  antibodies against peptides from both the NH2 and 
COOH termini (Fig. 3 A). Both antibodies recognize a protein 
of the expected molecular mass ( 113 kD) for the endogenous 
Q69YH5 in HeLa nuclear extracts (Fig. 4 A) and detect appro-
priately sized bands when tagged derivatives are exogenously 
expressed (Fig. S2, available at http://www.jcb.org/cgi/content/
full/jcb.200508154/DC1). We note that the antibody raised 
against the NH2-terminal peptide recognized an additional 
band in HeLa extracts of  65 kD, which has not been charac-
terized further.
Characterization of endogenous 
and tagged Q69YH5
Using the anti-peptide antisera, we confi  rmed that endogenous 
Q69YH5 interacts with PP1 in vivo. Affi  nity-purifi  ed  anti-
Q69YH5 antisera coimmunoprecipitated PP1γ from HeLa 
interphase nuclear lysate (Fig. 4 B, lane 3), and this coimmu-
noprecipitation was lost when the antibody was preincubated 
with the cognate peptide (Fig. 4 B, lane 4). Purifi  cation of en-
dogenous PP1 complexes from interphase nuclear lysates using 
microcystin affi  nity chromatography also verifi  ed that endoge-
nous Q69YH5 (Fig. 4 C, lane 2) is in a complex with PP1. 
Using HeLa cell fractions, we showed that endogenous Q69YH5 
is predominantly nuclear (Fig. 4 A). This was confi  rmed by 
immunostaining paraformaldehyde-fi  xed HeLa cells with anti-
Q69YH5, which revealed a widespread nucleoplasmic accumu-
lation of the protein, largely excluding nucleoli (Fig. 4 D). 
This staining pattern was lost upon preincubation of the anti-
body with the cognate peptide (unpublished data). Interestingly, 
immunolocalization of Q69YH5 in mitotic cells showed a dif-
fuse pattern in metaphase (Fig. 4 E) and an enhanced accumula-
tion on chromatin at anaphase and telophase (Fig. 4, F and G, 
arrowheads). This was similar to the distribution seen for PP1γ 
and encouraged us to examine the dynamic behavior of Q69YH5 
in live cells.
Table I. PP1-interacting proteins identiﬁ  ed by combined SILAC/proteomics
Accession number Protein name Isoform preference Molecular mass Number of unique 
  peptides quantiﬁ  ed
Canonical RVXF 
motif
References
kD
Known PP1 binding 
proteins
 P49750 ZAP3 None 219.9 50 + Tran et al., 2004
 Q75MG7 KPI-2 PP1γ 164.9 2 + Wang and Brautigan, 2002
 Q13625 p53bp2 PP1α 125.6 13 + Helps et al., 1995
 Q96QC0 P99/PNUTS PP1α 99.1 9 + Kreivi et al., 1997; Allen 
  et al., 1998
 Q96SB3 Neurabin  II/ 
 Spinophilin
None 89.5 21 + Hsieh-Wilson et al., 1999
 Q12972 NIPP1 PP1α 38.5 8 + Van Eynde et al., 1995; 
  Trinkle-Mulcahy et al., 1999
Novel PP1-
interacting proteins
  Q9H9B9 RIF1, isoform 4 PP1α 274.6 9 + —
 Q5VV35 Myopalladin PP1α 145.3 3 + —
 Q69YH5 Repo-Man PP1γ 112.7 4 + —
 Q01844 EWS PP1α 68.5 3 + —
 Q68CK8 KIAA1949 PP1α 67.9 4 + —
 O94842 LCP1 PP1γ 66.2 1 − —
 Q8NCH2 FLJ90254 PP1α 47.3 4 + —
 Q6ZUJ6 FLJ43651 PP1α 42.8 8 − —
 Q6UXN9 WD40 None 35.2 5 − —JCB • VOLUME 172 • NUMBER 5 • 2006  684
We therefore fused the Q69YH5 cDNA with EGFP and 
performed time-lapse imaging of FP-Q69YH5 transiently ex-
pressed in HeLa cells. Although a nucleoplasmic localization 
pattern similar to that observed for endogenous Q69YH5 is 
maintained throughout the G1, S, and G2 stages of the cell 
  cycle, it changes dramatically at M phase (Fig. 4 H). The 
  protein initially becomes diffuse throughout the cell as the nu-
clear membrane breaks down, and a faint accumulation is seen 
later on metaphase chromatin (Fig. 4 H, arrow). As the cell 
progresses to anaphase, there is a large accumulation of 
FP-Q69YH5 on chromatin (Fig. 4 H, box). Parallel time-lapse 
analysis of HeLa
EGFP-PP1γ cells indicates that the timing of this 
chromatin association of FP-Q69YH5 coincides with that of 
FP-PP1γ (Fig. 4 I, box). These data, along with further char-
acterization of the PP1 interaction, strongly indicate that 
Q69YH5 acts as a targeting subunit to recruit PP1 to chroma-
tin at anaphase. We have therefore named Q69YH5 Repo-
Man, for recruits PP1 onto mitotic chromatin at anaphase, to 
refl  ect this function.
Repo-Man has an essential cellular function
Having established that Repo-Man is recruited onto chromatin 
at anaphase and maintained there throughout interphase, we 
next addressed whether it is required for cell viability by reduc-
ing its levels using RNA interference (RNAi) knockdown. Four 
RNA duplexes targeted against Repo-Man were transiently 
transfected into HeLa cells, and the cells were monitored over 
time for viability, cell cycle progression, and levels of endoge-
nous Repo-Man. As shown in Fig. 5, two of the Repo-Man du-
plexes caused a >80% reduction in protein levels by 24 h after 
transfection (Fig. 5 A), and this reduced protein level was main-
tained for a further 24 h, with levels only starting to rise again 
72 h after transfection. The remaining two duplexes caused a 
smaller reduction in protein levels ( 30%). As a negative con-
trol, cells were transfected with a nonspecifi  c scrambled duplex 
(Fig. 5 A). A duplex targeting lamin A/C was used as a positive 
control for the transfection, causing a sustained reduction (>80%) 
in lamin A/C protein levels by 48 h after transfection (Fig. 5 A).
Cell cycle progression was also monitored over time by 
FACS analysis in cells transfected with Repo-Man duplex 1. 
Although there was a massive reduction in cell number over 
time after uptake of Repo-Man duplex versus scrambled (see 
the end of the paragraph), no signifi  cant differences were ob-
served in cell cycle distribution patterns (Fig. 5, B–D, vs. Fig. 5 E), 
suggesting that cells are dying regardless of cell cycle stage. 
A prominent sub-G1 peak is observed from 48 h after transfec-
tion onwards for cells treated with the Repo-Man duplex (Fig. 5, 
C and D), indicating an accumulation of apoptotic cells. This 
peak was not observed in cells treated with scrambled duplex, 
even at 72 h after transfection (Fig. 5 E). The small number of 
cells recovered after 72 h of Repo-Man knockdown (Fig. 5 D) 
compared with 72 h of treatment with scrambled duplex (Fig. 
5 E) is consistent with a reduction in cell viability when Repo-
Man levels are low (note the differences in scale in y axes).
Apoptosis of Repo-Man–depleted cells was confi  rmed by 
counterstaining with Annexin V–FITC and propidium iodide 24 h 
after transfection. At this stage, Annexin V binds to the external-
ized phosphatidyl serine characteristic of apoptotic cells, but 
propidium iodide is excluded because membrane integrity 
  remains intact. Cells treated with the scrambled duplex did not 
Figure 3.  Sequence analysis of Q69YH5. (A) 
Amino acid sequence for Q69YH5, highlight-
ing peptides identiﬁ  ed by mass spectrometry 
(pink), peptides used to raise afﬁ  nity-puriﬁ  ed 
antibodies (yellow), and the putative RVXF 
(PP1 binding) motif (green). For mutational 
analysis, the hydrophobic Val and Phe resi-
dues within this region (red) were mutated 
to Ala. (B) Clustal alignment of this region in 
Q69YH5 protein sequences from several ver-
tebrates. Identical residues are highlighted in 
yellow, and the highly conserved RVXF motif is 
outlined in red. The full sequence alignment is 
shown in Fig. S1, available at http://www.jcb.
org/cgi/content/full/jcb.200511068/DC1.REPO-MAN TARGETS PP1γ TO CHROMATIN • TRINKLE-MULCAHY ET AL. 685
show any signifi  cant Annexin V staining or propidium iodide 
incorporation (Fig. 5 F), whereas a high proportion of cells 
treated with Repo-Man duplex 1 bound Annexin V, and the ma-
jority of these cells did not incorporate propidium iodide (Fig. 
5 G). This indicated that membrane integrity was intact and that 
cells were therefore in an early stage of apoptosis. Further anal-
ysis of the mode of cell death during the 24–48-h time period 
was done by time-lapse imaging of cells transfected with either 
scrambled duplex or Repo-Man duplex 1, monitoring cells both 
by differential interference contrast (DIC) and by fl  uorescence 
imaging of Hoechst 33342–stained DNA for the characteristic 
membrane blebbing and nuclear fragmentation observed in 
apoptosis. The graph in Fig. 5 H sums up the scored results, 
with >60% of cells apoptosing in interphase after uptake of 
Repo-Man duplex 1. Less than 3% of these cells divide success-
fully over this time period, which explains why so few mitotic 
cells are observed in these knockdown experiments.
A soft agar colony–forming assay was also performed to 
assess cell viability. At 24 h after transfection, cells treated with 
either scrambled duplex or Repo-Man duplex 1 were transferred 
to the soft agar matrix at a clonal dilution. After 2 wk, there was 
a >50-fold difference in the number of colonies formed from 
cells treated with the scrambled duplex (Fig. 5 G, arrows) as 
compared with cells treated with the Repo-Man duplex (Fig. 
5 I). In summary, the data show that RNAi-induced reduction in 
Repo-Man levels promotes the onset of apoptosis within 24 h 
and severely reduces cell viability.
PP1 binding and chromatin recruitment 
are separable properties of Repo-Man
To characterize the interaction of Repo-Man with PP1 in more 
detail and to address whether this activity is linked with its chro-
matin binding, we analyzed a Repo-Man mutant in which the two 
conserved hydrophobic residues within the putative PP1 binding 
domain were changed to alanine residues (i.e., RVXF to RAXA; 
Fig. 3 A). Transient overexpression of this mutant FP–Repo-Man 
(Fig. 6 B) showed that it had a localization similar to that of wild-
type FP–Repo-Man (Fig. 6 A). Although both express at similar 
levels when transiently transfected into HeLa cells (not depicted), 
Western blotting reveals that only the wild type coprecipitates 
 endogenous  PP1γ (Fig. 6 C, lane 3), indicating that interaction 
with PP1 has been disrupted by mutation of this RVXF region.
We further tested the interaction of wild-type and RAXA 
mutant FP–Repo-Man with PP1γ by titrating varying levels of 
wild-type and mutant plasmid into HeLa
EYFP-PP1γ cells. Under 
normal conditions during interphase, PP1γ is found in various 
cytoplasmic and nucleoplasmic pools, along with a prominent 
nucleolar accumulation (Fig. 1 E), whereas Repo-Man is nucleo-
plasmic (Fig. 6 A). When high levels of wild-type FP–Repo-Man 
are overexpressed, however, the cytoplasmic and nucleolar 
pools of PP1γ are greatly diminished and the majority of the 
protein shows a similar nucleoplasmic distribution to Repo-Man 
as it is retargeted by the expressed protein. In contrast, overex-
pression of RAXA mutant FP–Repo-Man, which does not bind 
PP1 (Fig. 6 C), fails to relocalize PP1γ. This is best   illustrated 
Figure 4.  Q69YH5 interacts with endogenous PP1 and 
localizes to chromatin. (A) Western blot of HeLa cell frac-
tions with anti-Q69YH5 peptide antibodies shows that 
Q69YH5 is a predominantly nuclear protein (lane 3, 
  arrowhead). (B) When immunoprecipitated from inter-
phase nuclear lysates, endogenous Q69YH5 coprecipi-
tates endogenous PP1γ (lane 3, arrowhead). PP1 does not 
coprecipitate signiﬁ  cantly with preimmune sera (lane 2) or 
with anti-Q69YH5 antibody pretreated with the cognate 
peptide (lane 4). (C) Puriﬁ  cation of endogenous PP1 com-
plexes from interphase nuclear lysates using microcystin 
afﬁ   nity chromatography also shows that endogenous 
Q69YH5 (lane 2, arrowhead) is in a complex with PP1. 
(D–G) Staining of endogenous Q69YH5 with anti-
Q69HY5 antibody reveals that is predominantly nucleo-
plasmic and excluded from nucleoli (closed arrowhead) 
during interphase (D). Q69YH5 is predominantly diffuse 
in metaphase cells (E) but shows an accumulation on chro-
matin (open arrowheads) during anaphase (F) and telo-
phase (G). (H) This dynamic localization was conﬁ  rmed 
by time-lapse imaging of HeLa cells transiently expressing 
FP-Q69YH5 (top) stained with Hoechst 33342 (bottom). 
Images were taken every 3 min as the cell progressed 
from prophase to telophase. There is a faint accumulation 
of FP-Q69YH5 on chromatin at metaphase (arrow). (I) For 
comparison, a similar time-lapse proﬁ   le is shown for a 
HeLa
EGFP-PP1γ cell (top) stained with Hoechst 33342 
  (bottom). The white boxes indicate the time at which a sig-
niﬁ  cant recruitment of both FP-Q69YH5 and FP-PP1γ onto 
chromatin is observed. Bars, 10 μm.JCB • VOLUME 172 • NUMBER 5 • 2006  686
by comparing the localization of FP-PP1γ, which is exclusively 
nucleoplasmic at a 100:1 ratio of transfected wild-type to mutant 
Repo-Man expression plasmid, with the characteristic nucleolar 
accumulation of PP1γ seen at a 1:100 ratio of the same plasmids 
(Fig. 6 D). When both wild-type and mutant Repo-Man are overex-
pressed equally, an intermediate effect is observed. Thus, the ability 
of Repo-Man to infl  uence PP1 localization in a concentration-
dependent manner critically depends on the presence of a func-
tional PP1-interaction domain. We conclude that Repo-Man, 
which binds directly to PP1 and infl  uences localization, has the 
properties of a classic PP1-targeting subunit.
During mitosis, both PP1γ and Repo-Man simultaneously 
relocalize to chromatin at anaphase, which is most clearly illus-
trated by time-lapse fl  uorescence imaging of HeLa cells coex-
pressing FP-PP1γ and FP–Repo-Man (Fig. 7, A and B). Using 
a relocalization assay involving FP-PP1α, which does not accu-
mulate on chromatin at anaphase (Fig. 1 H), it was shown that 
Repo-Man is directly involved in recruitment of PP1 to chromatin. 
Increased levels of exogenous FP–Repo-Man caused an ectopic 
recruitment of PP1α to chromatin at anaphase (Fig. 7, C and D). 
Interestingly, this accumulation of Repo-Man on chromatin 
  appears to be independent of its ability to bind PP1. In cells 
  expressing both FP-PP1α and RAXA mutant FP–Repo-Man, 
the mutant Repo-Man accumulates on chromatin as normal, 
whereas FP-PP1α retains its typical mitotic localization pattern 
(Fig. 7, E and F). We conclude that Repo-Man is a targeting 
subunit that recruits PP1 to chromatin and that this recruitment 
occurs initially at the metaphase–anaphase transition during 
 mitosis.  Interestingly, overexpression of both wild-type and mu-
tant Repo-Man severely reduced both the total cell population 
and the number of mitotic cells observed, suggesting a deleteri-
ous effect on interphase cell function and/or entry into mitosis. It 
is therefore diffi  cult to assess the possible mitotic defects associ-
ated with these perturbations, although we have found some evi-
dence for chromosome condensation and segregation defects in 
cells overexpressing wild-type Repo-Man (Fig. S2).
RAXA mutant FP–Repo-Man acts 
as a dominant negative to displace 
Repo-Man–PP1𝗄 complexes from chromatin
As noted in the previous paragraph, the RAXA mutant of 
FP– Repo-Man accumulates on chromatin in a fashion similar to 
wild type but no longer recruits PP1. The binding of Repo-Man 
to chromatin is reversible, as shown by FRAP analysis (Fig. S2). 
Figure 5.  Depletion of Repo-Man by RNAi 
  induces apoptosis and decreases cell viability. 
(A) Western blot analyses of HeLa cells treated 
with various siRNA duplexes. Lysates were pre-
pared 24, 48, and 72 h after transfection. (B–D) 
FACS proﬁ  les for cells treated with Repo-Man 
duplex 1 and ﬁ  xed at 24 h (B), 48 h (C), and 
72 h (D) after transfection. (E) For comparison, 
a FACS proﬁ  le for cells treated with scrambled 
duplex and ﬁ  xed at 72 h is shown. (F and G) 
Cells treated with either scrambled duplex (F) 
or Repo-Man duplex 1 (G) for 24 h were also 
stained with Annexin V–FITC (green, arrows) 
and propidium iodide (red, arrowheads) to 
detect cells in early stages of apoptosis. Bars, 
40 μm. (H) Graph summarizes the fates ob-
served for HeLa cells by DIC imaging 24–48 h 
after transfection with either scrambled duplex 
(gray bars; n = 90) or Repo-Man duplex 1 
(black bars; n = 88). The graph shows the 
number of cells in each category as a percent-
age of total cells. (I and J) Soft agar assays 
were performed to detect cell viability via col-
ony formation (arrows) 2 wk after transfection 
with either scrambled duplex (I) or Repo-Man 
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Figure 6.  Mutation of the RVXF motif in Repo-Man disrupts interaction with PP1. (A and B) When transiently expressed, RAXA mutant FP–Repo-Man (B) 
shows a similar nucleoplasmic accumulation at interphase to wild type (A). Nucleoli are marked by arrowheads. (C) Unlike wild-type FP–Repo-Man (lane 3), 
the RAXA mutant does not coprecipitate endogenous PP1γ (lane 4), as shown by Western blotting. (D–G) Transient expression of wild-type but not RAXA mu-
tant FP–Repo-Man also retargets exogenous PP1, as demonstrated by titrating varying levels of the two plasmids into HeLa
EYFP-PP1γ cells. FP-PP1γ is shown in D 
(nucleoli indicated by arrowheads are enlarged in inset to compare PP1 levels), wild-type FP–Repo-Man in E, and RAXA mutant FP–Repo-Man in F. Merged 
images are shown in G. (H and I) A direct interaction is measured between wild-type CFP–Repo-Man and YFP-PP1γ using ﬂ  uorescence lifetime imaging mi-
croscopy/FRET analysis (H) but not between RAXA mutant CFP–Repo-Man and YPF-PP1γ (I). Color-coded ﬂ  uorescence lifetime maps are shown for each CFP 
construct (donor) in the presence of YFP-PP1γ (acceptor) and the respective quenched and unquenched lifetimes indicated on the graphs. Bars, 10 μm.
If a limited number of binding sites exist, we would predict that 
expression of high levels of RAXA mutant Repo-Man could 
displace endogenous Repo-Man–PP1 complexes on chromatin. 
To test this, we compared the anaphase chromatin targeting of 
FP-PP1γ in the presence of high levels of exogenously ex-
pressed RAXA mutant FP–Repo-Man (Fig. 8, C and D) to that 
observed normally (Fig. 8, A and B). A reduced accumulation of 
FP-PP1γ on chromatin was evident (Fig. 8, A–D, arrowheads), 
as compared with cells not expressing the mutant Repo-Man, 
and we therefore propose the displacement model shown in Fig. 
8 E. However, we note that almost no mitotic cells and relatively 
few interphase cells were detected expressing very high levels 
of RAXA mutant FP–Repo-Man, indicating that it adversely 
  affects cell viability (see the following paragraph). These data JCB • VOLUME 172 • NUMBER 5 • 2006  688
suggest that RAXA mutant Repo-Man can act as a dominant 
negative to displace endogenous Repo-Man–PP1γ complexes 
from chromatin during both anaphase and interphase.
The RNAi knockdown experiments (Fig. 5) showed that 
Repo-Man is important for cell viability. The dominant-  negative 
effect of the RAXA mutant provided a means to determine 
whether the cellular requirement for Repo-Man was connected 
to its role as a PP1-interacting protein. To do this, we compared 
the level of cell death resulting from either mock-transfection or 
transfection with the dominant-negative RAXA mutant of Repo-
Man. A much larger level of cell death was observed for cell 
populations expressing RAXA mutant FP–Repo-Man (Fig. 8, H 
and I). A more detailed inspection of the dying cells revealed that 
the majority of cell death occurred during interphase (Fig. 8 J, 
lane 3). We did not observe an obvious mitotic block, although a 
proportion of cells died either during or immediately after mitosis 
(Fig. 8 J, lanes 4 and 5). As noted in the previous paragraph, 
there was a severe reduction in the number of mitotic cells ob-
served, which is in agreement with the rapid onset of apoptosis. 
These data strongly argue that the essential role of Repo-Man in 
cell viability is directly related to its PP1-targeting activity.
Discussion
Distinct pools of PP1 play different roles in the cell, mediated 
by the binding of a common catalytic subunit to different 
  targeting proteins. In this study, we used a combination of 
time-lapse fl  uorescence imaging and a novel proteomics strat-
egy to characterize targeting proteins that can bind differen-
tially to the α and γ isoforms of PP1. Specifi  cally, we observed 
a pool of chromatin-bound PP1γ that is fi  rst recruited at ana-
phase and identifi   ed the targeting protein responsible. The 
Repo-Man–PP1 complex is loaded onto chromatin at anaphase, 
where it remains during interphase and is subsequently dis-
placed when cells enter prophase (Fig. 9). Further character-
ization of Repo-Man showed that perturbation of its PP1 
binding or expression level caused a variety of cell defects, as 
discussed later in this section.
We adopted a mass spectrometric strategy involving dif-
ferential stable isotope labeling, which allowed a quantitative 
comparison of the relative distribution of targeting subunits be-
tween the two PP1 isoforms and the ready elimination of non-
specifi   c contaminants. The identifi   cation of Repo-Man was 
facilitated by the enhanced sensitivity available using this 
method. For example, Repo-Man was not detected in previous 
studies using affi  nity chromatography with immobilized micro-
cystin, a cyclic peptide toxin that binds PP1 and PP2A cova-
lently (Moorhead et al., 1994). However, we found that 
Repo-Man does copurify among the proteins binding endoge-
nous PP1 that are enriched by microcystin chromatography 
from interphase nuclear lysates when we detect it using   anti–
Repo-Man antibodies (Fig. 4 C), suggesting it was previously 
Figure 7.  Overexpression of FP–Repo-Man 
ectopically recruits FP-PP1𝗂 to chromatin. 
(A and B) A series of time-lapse images taken 
every 3 min of a HeLa
EYFP-PP1γ cell (A) transiently 
expressing ECFP–Repo-Man (B) as it pro-
gresses from metaphase to telophase. Arrows 
mark chromatin regions. (C and D) Time-lapse 
series for a HeLa
EGFP-PP1α cell transiently express-
ing monomeric dsRed–Repo-Man (D), which 
retargets a signiﬁ  cant pool of FP-PP1α (C) to 
chromatin at anaphase (arrows) and retains it 
there. Note the lagging chromosomes  observed 
under these conditions (arrowheads). (E and F) 
Expression of RAXA mutant FP–Repo-Man 
(F) does not cause this retargeting of FP-PP1α 
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Figure 8.  Overexpression of RAXA mutant 
FP–Repo-Man displaces endogenous Repo-
Man–PP1𝗄 complexes from chromatin. (A–D) 
When RAXA mutant FP–Repo-Man (D) is ex-
pressed in HeLa
EGFP-PP1γ cells, signiﬁ  cantly 
lower levels of FP-PP1γ (C) are found on ana-
phase chromatin (arrowheads), compared 
with the levels observed (A) in cells expressing 
little or no mutant FP–Repo-Man (B). Bars, 10 μm. 
This indicates a dominant-negative effect, as 
depicted by E. (F–I) Time-lapse DIC imaging of 
HeLa cells after mock-transfection (F and G) or 
transfection with RAXA mutant FP–Repo-Man 
(H and I) was used to quantify the extent and 
type of cell death caused by these conditions, 
between 8 h (F and H) and 40 h (G and I) after 
transfection. Bars, 100 μm. (J) Summary of the 
fates observed for HeLa cells by DIC imaging 
after either mock-transfection (gray bars; n = 90) 
or transfection with RAXA mutant monomeric 
dsRed–Repo-Man (black bars; n = 163). Cell 
fates were divided into ﬁ  ve categories as indi-
cated, and the graph shows the number of 
cells in each category as a percentage of total 
cells. Bars, 10 μm.
Figure 9.  Localization of Repo-Man–PP1𝗄 complexes throughout the cell cycle. Based on the data presented in this study, we provide a depiction of the 
  localization of Repo-Man–PP1γ complexes (green) throughout the cell cycle, noting its initial loading onto chromatin at the metaphase–anaphase transition. 
Also shown is the key stage (red) at which both RNAi knockdown of endogenous Repo-Man and displacement of endogenous Repo-Man–PP1 complexes 
by the dominant-negative mutant induce apoptosis in interphase cells. Observed effects of overexpression of wild-type Repo-Man on mitotic cells are also 
indicated (blue).
missed because of its relatively low abundance compared with 
other PP1 binding factors. In addition to offering increased sen-
sitivity of detection, the SILAC approach also proved useful for 
identifying real PP1-specifi  c proteins among the large number 
of copurifying contaminants. This aids identifi  cation of  proteins 
that may be lost upon higher stringency purifi  cation strategies. 
Because as high as 90% of the copurifi  ed proteins proved to be 
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on inclusion of an internal negative control (cells expressing the 
FP tag alone). Any putative interacting proteins not specifi  c to 
PP1 contained equal amounts of 
12C/
14N-labeled peptides (from 
the FP cell line) to heavy isotope-labeled peptides (from the 
FP-PP1 cell lines). Furthermore, the ratio of the 
13C/
14N to 
13C/
15N-labeled peptides distinguished whether the targeting 
subunits bound preferentially to PP1α or -γ. Although we have 
applied this to the study of PP1, we envisage that a similar 
  strategy could be adopted to analyze and quantitate the differ-
ential interactions of any closely related proteins or modifi  ed 
versions of the same protein, with binding partners in other 
 biological  systems.
Time-lapse fl   uorescence imaging of the respective 
FP-PP1 stable cell lines revealed that both FP-PP1α and FP-PP1γ 
localize to kinetochores in metaphase; however, PP1α appears 
to be predominantly excluded from other chromatin regions at 
this stage, in contrast to PP1γ. Furthermore, we observe a dra-
matic increase in the accumulation of FP-PP1γ on chromatin at 
anaphase, where it is retained as daughter nuclei reform. This 
differential binding to chromatin explains why FP-PP1α ap-
pears in daughter nuclei much later and indicates the existence 
of chromatin binding factors that can selectively target PP1γ. 
Our strategy of screening PP1 binding proteins for factors show-
ing a preference for PP1γ thus enabled us to identify Repo-Man 
as a targeting subunit that mediates the regulated interaction of 
PP1γ with chromatin.
Repo-Man is a previously uncharacterized protein fi  rst de-
tected as being a member of a group of proteins whose mRNA 
expression correlated with that of known cell cycle–related pro-
teins (Walker, 2001). Interestingly, another of these proteins, 
borealin, has recently been identifi  ed as a novel chromosomal 
passenger protein required for stability of the bipolar mitotic 
spindle (Gassmann et al., 2004). More recently, Repo-Man was 
found among a group of cell cycle genes up-regulated in 
  aggressive neuroblastoma tumors (Krasnoselsky et al., 2005). 
We show that Repo-Man is a chromatin binding factor that also 
associates with PP1 via the canonical RVXF motif.
Although the loading of Repo-Man–PP1γ complexes onto 
chromatin occurs dramatically at the onset of anaphase, several 
lines of evidence suggest that the proteins remain associated in 
a complex bound to chromatin during interphase. Direct bio-
chemical and proteomic analysis of interphase nuclei showed 
that both endogenous and FP-tagged PP1 copurify with Repo-
Man, and fl  uorescent resonance energy transfer (FRET) experi-
ments confi  rm that PP1 and Repo-Man can interact directly 
during interphase (Fig. 6 H). It is important to note that although 
PP1γ shows a strong nucleolar accumulation during interphase, 
it represents only  20% of the total nuclear pool of PP1, with 
the remaining 80% in the nucleoplasm. The identity of the nu-
cleolar targeting subunit for PP1γ remains unknown, but our 
present data indicate that Repo-Man, along with NIPP1, ZAP3, 
p99/PNUTS, and other proteins, is involved in targeting pools 
of PP1γ to different nucleoplasmic sites, including chromatin, 
during interphase. Further evidence supporting the persistence 
of the Repo-Man–PP1γ complex on chromatin during inter-
phase comes from photobleaching studies, which show a  similar 
turnover rate for nucleoplasmic Repo-Man in interphase nuclei 
compared with Repo-Man on mitotic chromosomes (Fig. S2). 
Based on the photobleaching data, it appears that the protein is 
released from chromatin in late prophase, remaining predomi-
nantly diffuse until its recruitment back on to chromatin fi  rst at 
low levels during metaphase and then more dramatically at the 
onset of anaphase. Western blotting analysis revealed no major 
differences in Repo-Man levels at different stages of the cell 
  cycle (unpublished data), indicating that its accumulation on 
chromatin at anaphase results from relocalization of an existing 
pool and not new synthesis. It will be important to determine 
what controls this cell cycle–modulated association of Repo-
Man with chromatin and whether it is a direct (e.g., covalent 
modifi  cation) or indirect (e.g., interaction with another   factor) 
regulatory event.
Localization of PP1 to chromatin is in agreement with 
several of its known regulatory roles, which include dephos-
phorylation of histones and other mitotic phosphoproteins, reg-
ulation of chromosome decondensation and nuclear membrane 
assembly at the M–G1 transition, and regulation of both tran-
scription and chromatin remodeling during interphase (for re-
view see Ceulemans and Bollen, 2004). An important future 
goal, therefore, is the identifi  cation, by a similar SILAC/pro-
teomic approach, of new binding partners for Repo-Man, which 
will provide clues to the specifi  c regulatory pathways in which 
this PP1 complex is involved. Mapping the specifi  c regions of 
Repo-Man required for chromatin localization will also facili-
tate the identifi  cation of binding partners and/or the mechanism 
of chromatin interaction, which was shown here to be separable 
from its PP1 binding ability.
Changes in expression levels of many cell cycle–regulated 
kinases and phosphatases have serious consequences for cell 
viability (Mackeigan et al., 2005). Similarly, we fi  nd that deple-
tion of Repo-Man by RNAi knockdown leads to cell death by 
apoptosis, primarily in interphase. Overexpression of mutant 
Repo-Man that does not bind PP1 leads to a similar phenotype, 
suggesting that it is the loss of endogenous Repo-Man–PP1γ 
complexes from chromatin that initiates the apoptotic pathway, 
either directly or indirectly. There is no apparent mitotic block, 
and time-lapse imaging of chromatin in these cells does not pro-
vide any further clues to the disrupted pathway (Fig. S3, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200508154/DC1). 
The very rapid onset (within 24 h) of apoptosis results in very 
few cells surviving into mitosis (Fig. 5 H and Fig. 8 J), making 
it diffi  cult to assess the possible mitotic defects associated with 
these perturbations. For example, although analysis of large 
numbers of HeLa
EGFP-PP1γ cells treated with Repo-Man duplex 1 
revealed that, as in parental HeLa cells, the majority of cells die 
rapidly through apoptosis in interphase, only a few mitotic cells 
(<2% of the total population screened) could be found to con-
fi  rm that FP-PP1γ no longer accumulates on chromatin at ana-
phase and telophase under these conditions (Fig. S3).
Overexpression of wild-type Repo-Man also promotes apo    -
ptosis but with lower effi  ciency. In the small proportion of cells 
surviving into mitosis, we observed evidence for   chromosome 
segregation defects (Fig. S2). Collectively, the knockdown and 
overexpression data suggest that the Repo-Man–PP1γ complex 
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  including both interphase and mitosis. For example, Repo-Man 
may target PP1γ to dephosphorylate chromatin-  associated 
  factors, thus modulating their role in maintaining the degree of 
chromatin condensation throughout the cell cycle, which is crit-
ical for both cell division and viability. Additionally, the Repo-
Man–PP1γ complex may play an important role in modulating 
chromatin accessibility or the activity of specifi  c transcription 
factors during interphase. Disruption of this interphase role is 
the likely cause of the large-scale apoptosis observed upon 
knockdown of Repo-Man, whereas the chromosome segrega-
tion defects found upon overexpression of Repo-Man point to 
disruption of a mitotic regulatory role. Further work is therefore 
required to investigate the essential roles of the Repo-Man–PP1 
complex throughout the cell cycle.
Materials and methods
Plasmids and antibodies
Repo-Man was cloned from expressed sequence tags (IMAGE clones 
4803608 and 4838503; Geneservice Ltd.) using oligonucleotide primers, 
inserted into EGFP/EYFP/ECFP-C1 and monomeric dsRed-C1 FP vectors 
(Invitrogen) and conﬁ  rmed by restriction analysis and DNA sequencing. 
The Val and Phe residues of the putative PP1 binding motif (residues 
393 and 395) were changed to Ala using two-step recombinant PCR 
  mutagenesis. Polyclonal antibodies were raised in rabbits against Repo-
Man peptides (Fig. 3 A) and afﬁ  nity puriﬁ  ed using the cognate peptides 
(Eurogentec). Anti–lamin A/C, anti-PP1α, and anti-PP1γ antibodies were 
obtained from Santa Cruz Biotechnology, Inc., all HRP-conjugated second-
ary antibodies were obtained from Perbio Science, and microcystin-
  Sepharose was obtained from Upstate Biotechnology.
Stable cell lines
All FP-PP1 constructs and the HeLa
EGFP-PP1γ, HeLa
EYFP-PP1γ, and HeLa
EGFP stable 
cell lines were obtained as described previously (Trinkle-Mulcahy et al., 
2001, 2003). The HeLa
EGFP-PP1α stable cell line was established in a similar 
manner. Characterization of expressed FP-PP1 and FACS analyses were 
performed as previously described (Trinkle-Mulcahy et al., 2001).
Live cell imaging
Cells were cultured in glass-bottomed dishes (WILLCO; Intracel) and 
mounted on a wide-ﬁ  eld  ﬂ   uorescence microscope (DeltaVision Spectris; 
Applied Precision) ﬁ  tted with an environmental chamber (Solent Scientiﬁ  c) 
to maintain temperature at 37°C and a CoolMax charge-coupled device 
camera (Roper Scientiﬁ  c). Before imaging, growth medium was replaced 
with Phenol Red-free CO2 independent medium (Invitrogen). DNA was 
stained by incubating the cells for 30 min in medium containing 0.25 μg/ml 
Hoechst No. 33342 (Sigma-Aldrich). Cells were imaged using a 60× NA 
1.4 Plan-Apochromat objective. For time-lapse imaging, ﬁ  ve optical sec-
tions of 1 μM each were recorded every 3 min, with an exposure time of 
0.1 s for EGFP and 0.05 s for Hoechst 33342. DIC imaging was ob-
tained with the appropriate prism insert (Olympus). All ﬂ  uorescence time-
lapse images are presented as two-dimensional projections of the 
three-dimensional datasets. For high-resolution imaging, either 20 (inter-
phase cells) or 40 (mitotic cells) optical sections of 0.5 μM each were col-
lected, with exposure times of 0.5 s for EGFP. Similar settings were used 
to image ECFP- and EYFP-tagged proteins, using the appropriate ﬁ  lter sets 
(Chroma Technology Corp.). SoftWorX software (Applied Precision) was 
used for image acquisition, data deconvolution, and volume rendering. 
Fluorescence lifetime imaging microscopy/FRET experiments were per-
formed on a ﬂ  uorescent lifetime imaging system (Radiance 2100MP; Bio-
Rad Laboratories).
Immunoafﬁ  nity puriﬁ  cation of FP–PP1 complexes
Cells were grown for six cell divisions in L-arginine (HeLa
EGFP), L-arginine 
13C6
14N4 (HeLa
EGFP-PP1α), or L-arginine 
13C6
15N4 (HeLa
EGFP-PP1γ) labeling me-
dia before puriﬁ  cation. Nuclei were isolated from cells using a variation of 
a previously described technique (Andersen et al., 2002). Puriﬁ  ed nuclei 
were resuspended in RIPA buffer to solubilize proteins. Lysates from each 
cell line were mixed in a 1:1:1 ratio based on total protein concentration, 
and FP proteins were afﬁ  nity puriﬁ  ed using anti-GFP monoclonal antibodies 
(Roche) covalently coupled to protein G–Sepharose, as previously de-
scribed (Trinkle-Mulcahy et al., 2001). For the peptide elution experiment, 
the beads were incubated with an RVXF peptide from ZAP3 (sequence 
G  K  K  R  V  R  W  A  D  L  E  ) to elute PP1-interacting proteins. Immunoprecipitated pro-
teins were separated on NuPAGE 4–12% Bis-Tris gels and excised into 12 
slices. Peptides resulting from in-gel digestion were extracted from the gel 
pieces, desalted, concentrated on reverse phase–C18 tips, and eluted into 
96-well plates for automated mass spectrometric analysis.
For some experiments, the FPs from each nuclear lysate were afﬁ  nity 
puriﬁ  ed separately and subjected to one-dimensional SDS-PAGE, followed 
by silver staining or immunoblotting. For the far Western assays using 
35S-PP1, the substrate was prepared by in vitro translating PP1γ (in a 
pcDNA vector) in the presence of [
35S]methionine using the TNT T7 quick 
coupled transcription/translation system (Promega). Blots were blocked 
overnight with 10% milk powder in PBS, washed well with PBS, and incu-
bated with 
35S-PP1 for 4 h. Additional PBS washes were performed before 
exposure to x-ray ﬁ  lm to detect 
35S-PP1–labeled bands.
Mass spectrometry and data analysis
High-resolution mass spectrometric analysis was performed as described 
previously (Andersen et al., 2005) using the LTQ-FT-ICR mass spectrometer 
(Thermo Finnigan). Protein ratios were calculated for each arginine-
  containing peptide as the peak area of [
13C]Arg divided by the peak area 
of [
12C]Arg and the peak area of [
13C]/[
15N]Arg divided by the peak area 
of [
12C]Arg for each single scan mass spectrum. Peptide ratios for all argi-
nine-containing peptides sequenced for each protein were averaged. 
MS-Quant, a software program developed in house, was used to extract 
information from the Mascot HTML database search ﬁ  les (Matrix Science) 
and to evaluate the certainty in peptide identiﬁ  cation and in peptide abun-
dance ratio. The program is available as open source at http://msquant.
sourceforge.net.
RNAi
HeLa cells were transfected in 24-well plates with 1 μg of small interfering 
RNA (siRNA) duplexes (Dharmacon) using RNAiFect (QIAGEN) and either 
harvested or passaged 24 h after transfection.
Annexin V–FITC and soft agar assays
For the Annexin V–FITC assay, cells were grown and transfected with 
siRNA duplexes in 4-well chamber slides (Lab-Tek II; Nunc). After 24 h, the 
cells were stained using an Annexin V–FITC apoptosis detection kit 
(Abcam) and set up for live cell imaging.
For the soft agar assays, cells were grown and transfected with 
siRNA duplexes as described in the previous section and then trypsinized 
and mixed at a dilution of 4e
4 cell/ml with 0.3% agar in growth medium. 
This mixture was carefully pipetted onto 2 ml of base agar (0.5% agar in 
growth medium) in a 6-well plate at 0.5 ml/well and incubated at 37°C/5% 
CO2 for 2 wk.
Online supplemental material
Table S1 contains a comprehensive list of all proteins identiﬁ   ed in the 
SILAC/proteomic screen. Fig. S1 shows a Clustal alignment of Repo-Man 
protein sequences from several vertebrates. Fig. S2 shows Repo-Man de-
tected by Western blotting, mitotic defects associated with its overexpres-
sion, and analysis of its turnover kinetics throughout the cell cycle. Fig. S3 
shows DNA fragmentation induced by RNAi knockdown of Repo-Man and 
displacement of PP1γ from chromatin by overexpression of RAXA mutant 
Repo-Man. Video 1 shows a mitotic HeLa
EGFP-PP1α cell. Video 2 shows a mi-
totic HeLa
EGFP-PP1γ cell. Video 3 shows FP-Q69YH5 transiently expressed in 
a mitotic HeLa cell stained with Hoechst 33342 to mark chromatin. Video 4 
shows FP-PP1γ in a mitotic HeLa
EGFP-PP1γ stained with Hoechst 33342 to 
mark chromatin. Video 5 shows a mitotic HeLa
EGFP-PP1γ cell transiently ex-
pressing ECFP–Repo-Man. Video 6 shows a mitotic HeLa 
EGFP-PP1α cell tran-
siently expressing monomeric dsRed–Repo-Man. Video 7 shows a mitotic 
HeLa
EGFP-PP1α cell transiently expressing RAXA mutant monomeric dsRed–
Repo-Man. Video 8 shows a ﬁ  eld of HeLa cells mock-transfected and im-
aged 8–40 h after transfection. Video 9 shows a ﬁ   eld of HeLa cells 
transfected with RAXA mutant FP–Repo-Man and imaged 8–40 h after 
transfection. Online supplemental material is available at http://www.jcb.
org/cgi/content/full/jcb.200508154/DC1.
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